Morgan Stanley’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5K Buy
+2,820
New +$21K ﹤0.01% 6678
2025
Q3
Sell
-360
Closed -$2.27K 8314
2025
Q2
$2.27K Buy
+360
New +$2.81K ﹤0.01% 7202
2024
Q4
Sell
-38,105
Closed -$736K 8063
2024
Q3
$736K Buy
38,105
+37,914
+19,850% +$993K ﹤0.01% 5220
2024
Q2
$4.3K Sell
191
-852
-82% -$25.4K ﹤0.01% 6884
2024
Q1
$53.7K Sell
1,043
-4,568
-81% -$254K ﹤0.01% 6189
2023
Q4
$396K Buy
5,611
+4,992
+806% +$344K ﹤0.01% 5708
2023
Q3
$45.5K Buy
619
+37
+6% +$3.84K ﹤0.01% 6203
2023
Q2
$87K Buy
582
+349
+150% +$48.2K ﹤0.01% 6009
2023
Q1
$12.3K Sell
233
-99
-30% -$5.95K ﹤0.01% 6812
2022
Q4
$30.6K Sell
332
-167
-33% -$36.2K ﹤0.01% 6506
2022
Q3
$116K Buy
499
+187
+60% +$46.8K ﹤0.01% 6005
2022
Q2
$58K Buy
312
+240
+333% +$66.9K ﹤0.01% 6548
2022
Q1
$27K Buy
+72
New +$21.6K ﹤0.01% 7011
2021
Q4
Sell
-3
Closed -$2K 8074
2021
Q3
$2K Buy
3
+1
+50% +$493 ﹤0.01% 7674
2021
Q2
$1K Buy
+2
New +$981 ﹤0.01% 7621

Other funds holding PIII

Morgan Stanley's PIII Position: Q2 2026 in Review

Morgan Stanley opened a new position in P3 Health Partners (PIII) in Q2 2026: 2,820 shares worth $30.5K. The stake represents ﹤0.01% of the portfolio and ranks #6678 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in PIII as recently as Q2 2025.

Morgan Stanley first reported a position in PIII in Q2 2021 and has held it in 15 quarters since. The position peaked at $736K in Q3 2024. 18 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

  • Morgan Stanley held 2,820 shares of P3 Health Partners worth $30.5K as of Q2 2026.
  • P3 Health Partners was a new Morgan Stanley position in Q2 2026.
  • P3 Health Partners made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6678 holding.
  • Morgan Stanley first reported a position in P3 Health Partners in Q2 2021 and has held it in 15 quarters since.
  • Morgan Stanley's P3 Health Partners position peaked at $736K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.